Ruixin Liu

Affiliations: 
Anatomy Peking University, Beijing, Beijing Shi, China 
Google:
"Ruixin Liu"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shi J, Bao G, Hong J, et al. (2021) Deciphering CT texture features of human visceral fat to evaluate metabolic disorders and surgery-induced weight loss effects. Ebiomedicine. 69: 103471
Hong J, Bo T, Xi L, et al. (2021) Reversal of functional brain activity related to gut microbiome and hormones after VSG surgery in patients with obesity. The Journal of Clinical Endocrinology and Metabolism
Zhang Z, Wu Q, He Y, et al. (2021) Overexpression Enhances Expression . Frontiers in Endocrinology. 12: 634191
Lu J, Wang S, Li M, et al. (2020) Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes among Normoglycemic Chinese Adults: Findings From the 4C Study. Diabetes Care
Zhang D, Zhang J, Fu X, et al. (2020) Mesoporous anion-cation-codoped Co9S8 nanorings for enhanced electrocatalytic oxygen evolution reactions. Nanotechnology
Chen M, Lu P, Ma Q, et al. (2020) β dysfunction contributes to adiposity by regulating the cross-talk of mature adipocytes and preadipocytes. Science Advances. 6: eaax9605
Ye L, Gu W, Chen Y, et al. (2019) The impact of shift work on glycemic characteristics assessed by CGM and its association with metabolic indices in non-diabetic subjects. Acta Diabetologica
Li W, Liu R, Li X, et al. (2019) Saxagliptin alters bile acid profiles and yields metabolic benefits in drug naïve overweight or obese type 2 diabetes. Journal of Diabetes
Sun Y, Wang R, Zhao S, et al. (2018) FGF9 inhibits browning program of white adipocytes and associates with human obesity. Journal of Molecular Endocrinology
Zhao D, Zhao S, Wang X, et al. (2018) Clinical and Physiological Characterization of Elevated Plasma Glucagon-Like Peptide-1 Levels (Hyperglipemia) in a Dipeptidyl Peptidase IV Mutation Carrier. Frontiers in Endocrinology. 9: 62
See more...